CHRN logo

CHRONOSCALE HOLDINGS CORP

CHRNNASDAQ
πŸ† #4425 by market capEarnings Feb 22 Β· PostUS Equity
$7.95β–Ό $0.56 (βˆ’6.58%)
Market closed Β· at close
πŸ””
Track CHRN
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 6.6%
7dβ–Ό 23.6%
14dβ–Ό 25.8%
30dβ–Ό 46.2%
ytdβ–Ό 8.0%
1yβ–² 98.5%
🏦Market Cap
$28M
Small Cap
πŸ“ˆRevenue Growth (YoY)
β€”
πŸ“ŠGross Margin
β€”
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
β€”
Otter Score
β€”
Insufficient data

Trading Snapshot

Day Range
$7.71 – $8.17
52-Week Range
$3.50 – $30.00
Volume (shares)
225,991
Avg Volume (shares)
β€”
Shares Outstanding
3.6M
Next Earnings
2027-02-22

Fundamentals Snapshot

Annual Revenue
β€”
Last Q Revenue
$41M
P/E Ratio
β€”
P/S Ratio
β€”
EPS (TTM)
β€”
Dividend Yield
β€”
CHRN logo

CHRONOSCALE HOLDINGS CORP

CHRN
Financial Trends

Financial history unavailable.

StockOtter Β· stockotter.space

About CHRONOSCALE HOLDINGS CORP

ChronoScale Corporation designs and develops a compute platform to support artificial intelligence (AI) workloads. The company focuses on large-scale deployments and provides dedicated compute environments engineered for performance, consistency, and long-term operational execution. The company is based in Dallas, Texas. ChronoScale Corporation operates as a subsidiary of Applied Digital Corporation.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Insufficient data
β€”/100

Analyst Ratings

β“˜
Consensus
Buy
8 analysts
Strong Buy3
Buy4
Hold1
Sell0
Strong Sell0
Ratings as of Nov 2026

Latest News & Updates

GlobeNewsWireΒ·4d ago

STN and ChronoScale Form Partnership to Develop Odessa AI Campus

Initial phase planned for 2027, with additional expansion planned to support a leading frontier AI lab Initial phase planned for 2027, with additional expansion planned to support a leading frontier AI lab

GlobeNewsWireΒ·4d ago

ChronoScale Announces New Development Partnership to Accelerate AI Compute Capacity Deployment, Supported by a Significant Capital Raise

Initial deployment for a leading frontier AI lab The initial deployment carries a total contract value of $7.5 billion over six years Up to $750 million financing with participation by four strategic investors, including

PRNewsWireΒ·Oct 21

Soluna Agrees to Form Strategic Partnership with Applied Digital to Develop Wind-Powered AI Data Center in Texas

Facility to be powered by Briscoe Wind Farm; ChronoScale signs letter of intent for triple-net lease ALBANY, N.Y., Oct. 21, 2026 /PRNewswire/ -- Soluna Holdings, Inc. (Nasdaq: SLNH) ("Soluna"), a developer of green data

GlobeNewsWireΒ·Oct 15

ChronoScale Reports Fiscal First Quarter 2027 Results

MENLO PARK, Calif., Oct. 15, 2026 (GLOBE NEWSWIRE) -- ChronoScale Holdings Corporation (NASDAQ: CHRN) (β€œChronoScale” or the β€œCompany”), an accelerated compute platform purpose-built to support demanding artificial intell

GlobeNewsWireΒ·Oct 1

Wandercraft Acquires Ekso Bionics, Uniting Two Pioneers to Advance and Expand Robotic Mobility

NEW YORK and SAN RAFAEL, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Wandercraft today announced the acquisition of Ekso Bionics, Inc. from a subsidiary of ChronoScale Holdings Corporation (Nasdaq: CHRN), bringing together

GlobeNewsWireΒ·Oct 1

ChronoScale Announces Agreements Bringing Total Company Contracted Run-Rate Revenue to $1 Billion and Sale of Ekso Bionics Business Unit

Expanded agreement with an existing AI infrastructure customer and new customer agreement increases contracted deployment pipeline and is expected to drive Company annualized revenue run rate to $1 billion by calendar Q3